Author:
Hampson Lisa V.,Izem Rima
Publisher
Springer International Publishing
Reference55 articles.
1. Neuenschwander, B., S. Roychoudhury, and H. Schmidli, On the use of co-data in clinical trials. Statistics in Biopharmaceutical Research, 2016. 8(3): p. 345-354.
2. Higgins, J.P. and J. Thomas. Cochrane Handbook for Systematic Reviews of Interventions. 2022 [cited 2022 September]; Available from: www.training.cochrane.org/handbook.
3. Concato, J. and J. Corrigan-Curay, Real-World Evidence — Where Are We Now? New England Journal of Medicine, 2022. 386(18): p. 1680-1682.
4. Izem, R., et al., Real-World Data as External Controls: Practical Experience from Notable Marketing Applications of New Therapies. Therapeutic Innovation & Regulatory Science, 2022: p. 1-13.
5. Levenson, M., et al., Statistical Consideration for Fit-for-Use Real-World Data to Support Regulatory Decision Making in Drug Development. Statistics in Biopharmaceutical Research, 2022: p. 1-8.